Literature DB >> 11122433

Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas.

A Kabashima1, T Yao, K Sugimachi, M Tsuneyoshi.   

Abstract

AIMS: The differences in phenotypic expression between multiple early gastric carcinomas (EGCs) and solitary EGCs were evaluated in this study. METHODS AND
RESULTS: Fifty-three cases (53 lesions) of solitary EGCs and 50 cases (112 lesions) of multiple EGCs were studied. According to the classification of intestinal metaplasia, the phenotypes of carcinomas and background mucosa were classified into four categories-complete intestinal type, incomplete intestinal type, gastric type and unclassified type-based on the combination of expression of CD10 (small intestinal brush border), MUC2 (intestinal goblet cell), HGM (gastric foveolar epithelium) and Con A (gastric pyloric glands). The incidence of gastric-type carcinomas (48%) and the incidence of incomplete intestinal-type background mucosa (75%) among the multiple EGCs was higher than among the solitary EGCs. There was a significant difference in distribution of phenotypic expression of carcinomas and background mucosa between the solitary EGCs and the multiple EGCs, the latter being associated with incomplete intestinal metaplasia.
CONCLUSIONS: Both the carcinomas and the background mucosa of multiple EGCs have an unstable status, since they more commonly possess the hybrid phenotype of the stomach and the small intestine than does solitary EGC. Such instability is considered to contribute to a high neoplastic potential and the multiple occurrence of carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122433     DOI: 10.1046/j.1365-2559.2000.01008.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

2.  Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features.

Authors:  Takashi Yao; Takashi Utsunomiya; Masafumi Oya; Kenichi Nishiyama; Masazumi Tsuneyoshi
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.

Authors:  Reiko Kumagai; Kenichi Kohashi; Shunsuke Takahashi; Hidetaka Yamamoto; Minako Hirahashi; Kenichi Taguchi; Kenichi Nishiyama; Yoshinao Oda
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

5.  Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.

Authors:  Takashi Murakami; Takashi Yao; Hiroyuki Mitomi; Takashi Morimoto; Hiroya Ueyama; Kenshi Matsumoto; Tsuyoshi Saito; Taro Osada; Akihito Nagahara; Sumio Watanabe
Journal:  Gastric Cancer       Date:  2015-04-18       Impact factor: 7.370

6.  Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer.

Authors:  Akiko Shiotani; Ken Haruma; Noriya Uedo; Hiroyasu Iishi; Ryu Ishihara; Masaharu Tatsuta; Mitutaka Kumamoto; Yukinori Nakae; Shingo Ishiguro; David Y Graham
Journal:  Virchows Arch       Date:  2006-10-13       Impact factor: 4.064

7.  Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.

Authors:  Satoshi Ikarashi; Ken Nishikura; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Gastric Cancer       Date:  2012-07-25       Impact factor: 7.370

8.  Gastric adenocarcinoma of fundic gland type: Endoscopic and clinicopathological features.

Authors:  Gen Tohda; Takeshi Osawa; Yasuyuki Asada; Masaki Dochin; Shintarou Terahata
Journal:  World J Gastrointest Endosc       Date:  2016-02-25

9.  Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer.

Authors:  Ayako Goto; Minako Hirahashi; Mikako Osada; Kazuhiko Nakamura; Takashi Yao; Masazumi Tsuneyoshi; Ryoichi Takayanagi; Yoshinao Oda
Journal:  Virchows Arch       Date:  2011-05-03       Impact factor: 4.064

10.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.